Skip to main content

and
  1. No Access

    Article

    Investigation of BRAFand CTNNB1 activating mutations in adrenocortical tumors

    Background: Activating mutations of the BRAF oncogene play a central role in the development of various cancer types, but their role in human adrenocortical tumors is unknown. At variance...

    G. Masi, E. Lavezzo, M. Iacobone, G. Favia in Journal of Endocrinological Investigation (2009)

  2. No Access

    Article

    The role of 21-hydroxylase in the pathogenesis of adrenal masses: Review of the literature and focus on our own experience

    An exaggerated response of 17-hydroxyprogesterone (17-OHP) to exogenous ACTH stimulation has been found in 30 to 70% of patients with incidentally discovered adrenal tumors, supporting the concept that congeni...

    L. Barzon, P. Maffei, N. Sonino, C. Pilon in Journal of Endocrinological Investigation (2007)